期刊文献+

少突-星形细胞肿瘤的CT和MRI表现 被引量:7

CT and MRI manifestations of oligoastrocytic tumors
下载PDF
导出
摘要 目的探讨少突-星形细胞肿瘤的CT和MRI特征性表现。方法回顾性分析经手术病理证实的20例少突-星形细胞肿瘤的CT和MRI表现。结果 20例中,少突-星形细胞瘤18例,间变性少突-星形细胞瘤2例,均发生于大脑半球,以额叶较常见,可跨脑叶生长,部分发生于胼胝体。10例肿瘤出现囊变,5例肿瘤见钙化。CT见病灶多呈混杂密度,增强后无强化或不均匀性强化。MRI示肿瘤多以长或稍长T1长T2信号为主;DWI 5例肿瘤实质部分呈稍高信号,ADC值约(1.40±0.25)×10-3mm2/s;增强后肿瘤呈环状、花环状或不均匀性强化。肿瘤周围多可见轻度水肿。结论少突-星形细胞肿瘤多位于大脑半球,以实性病灶为主,CT和MRI表现具有一定特征性。 Objective To investigate the characteristic CT and MRI findings of oligoastrocytic tumors.Methods CT and MRI findings in 20 patients of oligoastrocytic tumors proved with operation and pathology were analyzed retrospectively.Results Among 20 patients,there were 18 oligoastrocytomas and 2 anaplastic oligoastrocytomas.Cerebral hemisphere was the predilection site of oligoastrocytic tumors,which mostly located in the frontal lobe.Some tumors extended to other lobes,some located in the corpus callosum.Cystic degeneration was found in 10 and calcification in 5 patients.On CT images,tumors tended to appear as mixed density,no enhancement or heterogeneous enhancement was found.Most tumors appeared as low or slight low signal intensity on T1WI and high signal intensity on T2WI.Five oligoastrocytomas showed slightly high signal intensity on DWI,and the mean of ADC values was(1.40±0.25)×10-3 mm2/s.Rim,wreath enhancement or heterogeneous enhancement were observed.Slight peripheral edema of focus was observed in most of the tumors.Conclusion Most oligoastrocytic tumors locate in cerebral as substantial neoplasm.Oligoastrocytic tumor has characteristic imaging appearances on CT and MRI.
出处 《中国医学影像技术》 CSCD 北大核心 2011年第6期1125-1128,共4页 Chinese Journal of Medical Imaging Technology
关键词 少突-星形细胞瘤 大脑半球 磁共振成像 体层摄影术 X线计算机 Oligoastrocytoma Cerebral hemisphere Magnetic resonance imaging Tomography X-ray computed
  • 相关文献

参考文献10

二级参考文献54

共引文献195

同被引文献52

  • 1章翔,易声禹,李安民,张志文,张剑宁,付相平,费舟,杨利孙,黄高升,DiemathHE,piotrowskiWP.混合型胶质细胞瘤的诊断与治疗[J].第四军医大学学报,1995,16(3):214-217. 被引量:3
  • 2贾洪顺,梁文,孙涛.颅内少支-星形细胞瘤15例MRI表现[J].实用医学杂志,2006,22(3):306-307. 被引量:5
  • 3Louis DN, Ohgak H, Wiestler OD, et al. The 2007 WHO classifica- tion of tumours of the central nervous system. Acta Neuropathol, 2007,114:97.
  • 4Buhl R, Hugo HH, Stark AM,et al. Clinical experiences with oligoas- trocytomas WHO grade 1I and Ill. Neurosurg Rev,2004,27:2182.
  • 5Scheie D, Meling TR, Cvancarova M, et al. Prognostic variables in ol- igodendroglial tumors: a single-institution study of 95 cases. Neuro Onco1,2011,13 : 1225.
  • 6Cairncross G, Berkey B, Shaw E, et al. Phase III trial of chemothera- py plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol,2006,24:2707.
  • 7Engelhard HH, Ste|ea A, Mundt A. Oligodendroglioma and anaplas- tic oligodendroglioma: ehnical features, treatment, and prognosis. Surg Neuro1,2003 ,60 :443.
  • 8Sherman JI-I, Prevedelio DM, Shah L, et al. MR imaging characteris- tics of oligodendroglial tumors with assessment of lp/19q deletion status. Acta Neurochir ( Wien ) , 2010,152 : 1827.
  • 9White ML,Zhang Y, Kirby P, et al. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendro- gliomas? AJNR,2005,26:784.
  • 10Martee L. Hensley, Kamn I,. Hagerly,et al. American Stn'iety cf Clinical Ont'ology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Proteetants. [ J]. JCO, 2009, 27( 1 ):127-145.

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部